Driven by the need for a better way to prioritize targets for drug development, the Icahn School of Medicine at Mount Sinai has led the development of a novel “genetic priority score” (GPS) that will integrate various types of human genetic data into a single easy-to-interpret score.
These start-ups impressed the jury at the 10th anniversary of the BioRiver Boost! competition – Biotech Investments
EQS-News: BioRiver e.V. / Key word(s): Miscellaneous Biotechnology applications for the future: These start-ups impressed the jury at the 10th anniversary of the BioRiver Boost!